Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression

Tumor cells often produce high levels of reactive oxygen species (ROS) and display an increased ROS scavenging system. However, the molecular mechanism that balances antioxidative and oxidative stress in cancer cells is unclear. Here, we determined that oncogenic multiple copies in T-cell malignancy...

Full description

Saved in:
Bibliographic Details
Published inOncogenesis (New York, NY) Vol. 6; no. 4; p. e313
Main Authors Tseng, H-Y, Chen, Y-A, Jen, J, Shen, P-C, Chen, L-M, Lin, T-D, Wang, Y-C, Hsu, H-L
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 10.04.2017
Nature Publishing Group
Subjects
13/1
13/105
13/109
13/31
631/67/1612/1350
631/67/2327
631/67/327
64/60
82/51
82/80
Apoptosis
Cell Biology
Gene expression
Human Genetics
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Original
original-article
Oxidative stress
Proteins
Signal transduction
Tumorigenesis
Online AccessGet full text

Cover

More Information
Summary:Tumor cells often produce high levels of reactive oxygen species (ROS) and display an increased ROS scavenging system. However, the molecular mechanism that balances antioxidative and oxidative stress in cancer cells is unclear. Here, we determined that oncogenic multiple copies in T-cell malignancy 1 (MCT-1) activity promotes the generation of intracellular ROS and mitochondrial superoxide. Overexpression of MCT-1 suppresses p53 accumulation but elevates the manganese-dependent superoxide dismutase (MnSOD) level via the YY1-EGFR signaling cascade, which protects cells against oxidative damage. Conversely, restricting ROS generation and/or targeting YY1 in lung cancer cells effectively inhibits the EGFR-MnSOD signaling pathway and cell invasiveness induced by MCT-1. Significantly, MCT-1 overexpression in lung cancer cells promotes tumor progression, necrosis and angiogenesis, and increases the number of tumor-promoting M2 macrophages and cancer-associated fibroblasts in the microenvironment. Clinical evidence further confirms that high expression of MCT-1 is associated with an increase in YY1, EGFR and MnSOD expression, accompanied by tumor recurrence, poor overall survival and EGFR mutation status in patients with lung cancers. Together, these data indicate that the MCT-1 oncogenic pathway is implicated in oxidative metabolism and lung carcinogenesis.
ISSN:2157-9024
2157-9024
DOI:10.1038/oncsis.2017.13